Author Index: E

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Earle, C.
• THE EFFECT OF FECAL IMMUNOCHEMICAL TEST THRESHOLD ON COLORECTAL SCREENING OUTCOMES
Eaton, J.
• RESOURCE ALLOCATION DECISIONS AND BUDGETARY POLICIES UNDER CONDITIONS OF UNCERTAINTY
Efthimiou, O.
• TREATMENT STRATEGIES FOR MULTIPLE MYELOMA IN ELDERLY PATIENTS: A NETWORK META-ANALYSIS
Eiring, O.
• MULTI-CRITERIA DECISION ANALYSIS OF PHARMACOLOGICAL MAINTENANCE TREATMENT OPTIONS IN BIPOLAR DISORDER: EVALUATION OF AN EXPEDITE APPROACH
El-Banna, A.
• DISCRETE EVENT SIMULATION MODELLING TO ANALYSE INNOVATIONS IN CANCER PATHOLOGY SERVICES
El-Khatib, M.
• CLINICIAN-IDENTIFIED PRIORITIES FOR MEDICATION SAFETY IN PRIMARY CARE: A PRIORITIZE STUDY
Elbasha, E. H.
• COST-EFFECTIVENESS OF BEZLOTOXUMAB+STANDARD OF CARE (SOC) VERSUS PLACEBO+SOC FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED STATES
Elliott, R. A.
• ECONOMIC EVALUATION OF A COMMUNITY BASED DIAGNOSTIC PATHWAY TO STRATIFY ADULTS AT RISK OF ALCOHOLIC LIVER DISEASE
Elwy, A. R.
• IMPROVING DIAGNOSTIC DECISION MAKING FOR A RARE DISEASE: IDENTIFYING BARRIERS TO EARLY DIAGNOSIS OF SCHWANNOMATOSIS
Endel, G.
• IMPROVING CERVICAL CANCER PRIMARY SCREENING AND DIAGNOSTIC FOLLOW-UP IN AUSTRIA – A DECISION-ANALYTIC BENEFIT-HARM ANALYSIS

• HEALTH-ECONOMIC EVALUATION OF HPV-BASED CERVICAL CANCER PRIMARY SCREENING COMPARED TO CYTOLOGY OR P16/KI-67 DUAL-STAINING – A DECISION-ANALYSIS FOR THE AUSTRIAN HEALTH CARE CONTEXT
Engelhardt, E.
• ONCOLOGIST AND PATIENT QUESTIONS DURING CONSULTATIONS ABOUT ADJUVANT CANCER TREATMENT: A SHARED DECISION-MAKING PERSPECTIVE
Engelhardt, E. G.
• DISCLOSING THE UNCERTAINTY OF PROGNOSTIC ESTIMATES IN BREAST CANCER: CURRENT PRACTICES AND PATIENTS' AWARENESS OF UNCERTAINTY
Enns, E.
• COMPARISON OF CALIBRATION METHODS FOR NATURAL HISTORY SIMULATION MODELS
Eriksson, J.
• ASSOCIATION OF DISEASE PROGRESSION, HEALTH-RELATED QUALITY OF LIFE, AND UTILITY IN PATIENTS WITH ADVANCED, NONFUNCTIONAL, WELL-DIFFERENTIATED GASTROINTESTINAL OR LUNG NEUROENDOCRINE TUMORS IN THE PHASE 3 RADIANT-4 TRIAL
escobar-Viera, C.
• UTILIZING ELECTRONIC HEALTH RECORD DOCUMENTATION TO MEASURE VALUE FOR PROSTATE CANCER CLINICAL CARE
Esnaola, N.
• SELECTIVE VERSUS ROUTINE SURGICAL RESECTION FOR RECTAL CANCER FOLLOWING NEOADJUVANT CHEMORADIATION AND CLINICAL COMPLETE RESPONSE
Esteban, E.
• IMPROVING CERVICAL CANCER PRIMARY SCREENING AND DIAGNOSTIC FOLLOW-UP IN AUSTRIA – A DECISION-ANALYTIC BENEFIT-HARM ANALYSIS

• HEALTH-ECONOMIC EVALUATION OF HPV-BASED CERVICAL CANCER PRIMARY SCREENING COMPARED TO CYTOLOGY OR P16/KI-67 DUAL-STAINING – A DECISION-ANALYSIS FOR THE AUSTRIAN HEALTH CARE CONTEXT
Evans, G.
• COST-EFFECTIVENESS OF RISK-BASED STRATIFIED BREAST CANCER SCREENING
Evans, R.
• PREDICTORS OF PATIENT PREFERENCES FOR WHOLE BODY MAGNETIC RESONANCE IMAGING COMPARED WITH STANDARD STAGING PATHWAYS FOR THE INVESTIGATION OF SYMPTOMS OF SUSPECTED COLORECTAL OR LUNG CANCER
Evers, S.
• A COMPARISON OF PATIENTS' AND HEALTHCARE PROFESSIONALS' PREFERENCES FOR THE CHARACTERISTICS OF DISEASE MODIFYING DRUGS IN DECISION MAKING ABOUT MULTIPLE SCLEROSIS TREATMENT
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z